| [1] |
Kovesdy CP. Management of hyperkalaemia in chronic kidney disease[J]. Nat Rev Nephrol, 2014, 10(11):653-662. DOI: 10.1038/nrneph.2014.168.
|
| [2] |
Lehnhardt A, Kemper MJ. Pathogenesis, diagnosis and management of hyperkalemia[J]. Pediatr Nephrol, 2011, 26(3):377-384. DOI: 10.1007/s00467-010-1699-3.
|
| [3] |
Weiner ID, Wingo CS. Hyperkalemia: a potential silent killer[J]. J Am Soc Nephrol, 1998, 9(8):1535-1543.
|
| [4] |
Kovesdy CP. Management of hyperkalemia: an update for the internist[J]. Am J Med, 2015, 128(12):1281-1287. DOI: 10.1016/j.amjmed.2015.05.040.
|
| [5] |
Parham WA, Mehdirad AA, Biermann KM, et al. Hyperkalemia revisited[J]. Tex Heart Inst J, 2006, 33(1):40-47.
|
| [6] |
Ho K. A critically swift response: insulin-stimulated potassium and glucose transport in skeletal muscle[J]. Clin J Am Soc Nephrol, 2011, 6(7):1513-1516. DOI: 10.2215/CJN.04540511.
|
| [7] |
高勇.胰岛素信号通路中GLUT4的作用机制研究[D].浙江大学, 2006.
Gao Y. Study on the action mechanism of GLUT4 in insulin signaling pathway[D]. Zhejiang University, 2006.
|
| [8] |
Clausen T. Na+-K+ pump regulation and skeletal muscle contractility[J]. Physiol Rev, 2003, 83(4):1269-1324. doi: 10.1152/physrev.00011.2003
|
| [9] |
程素蓉.血透机的透析原理及一般故障排除[J].医疗装备, 2005, 18(10):61. DOI: 10.3969/j.issn.1002-2376.2005.10.046.
Cheng SR. Dialysis principle and general trouble shooting of hemodialysis machine[J]. Chin J Med Dev, 2005, 18(10):61. DOI: 10.3969/j.issn.1002-2376.2005.10.046.
|
| [10] |
Sterns RH, Grieff M, Bernstein PL. Treatment of hyperkalemia: something old, something new[J]. Kidney Int, 2016, 89(3):546-554. DOI: 10.1016/j.kint.2015.11.018.
|
| [11] |
Bomback AS, Woosley JT, Kshirsagar AV. Colonic necrosis due to sodium polystyrene sulfate (Kayexalate)[J]. Am J Emerg Med, 2009, 27(6):751-753. DOI: 10.1016/j.ajem.2008.10.002.
|
| [12] |
Watson M, Abbott KC, Yuan CM. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia[J]. Clin J Am Soc Nephrol, 2010, 5(10):1723-1726. DOI: 10.2215/CJN.03700410.
|
| [13] |
Cleland JG, Coletta AP, Torabi A, et al. Clinical trials update from the European Society of Cardiology Meeting 2010: SHIFT, PEARL-HF, STAR-heart, and HEBE-Ⅲ[J]. Eur J Heart Fail, 2010, 12(11):1261-1264. DOI: 10.1093/eurjhf/hfq186.
|
| [14] |
Sterns RH, Rojas M, Bernstein P, et al. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?[J]. J Am Soc Nephrol, 2010, 21(5):733-735. DOI: 10.1681/ASN.2010010079.
|
| [15] |
Li T, Vijayan A. Insulin for the treatment of hyperkalemia: a double-edged sword?[J]. Clin Kidney J, 2014, 7(3):239-241. DOI: 10.1093/ckj/sfu049.
|
| [16] |
Bushinsky DA, Williams GH, Pitt B, et al. Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia[J]. Kidney Int, 2015, 88(6):1427-1433. DOI: 10.1038/ki.2015.270.
|
| [17] |
Vu BN, De Castro AM, Shottland D, et al. Patiromer: the first potassium binder approved in over 50 years[J]. Cardiol Rev, 2016, 24(6):316-323. doi: 10.1097/CRD.0000000000000123
|
| [18] |
Stavros F, Yang A, Leon A, et al. Characterization of structure and function of ZS-9, a K+ selective ion trap[J]. PLoS One, 2014, 9(12):e114686. DOI: 10.1371/journal.pone.0114686.
|
| [19] |
Kosiborod M, Rasmussen HS, Lavin P, et al. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial[J]. JAMA, 2014, 312(21):2223-2233. DOI: 10.1001/jama.2014.15688.
|
| [20] |
Packham DK, Rasmussen HS, Lavin PT, et al. Sodium zirconium cyclosilicate in hyperkalemia[J]. N Engl J Med, 2015, 372(3):222-231. DOI: 10.1056/NEJMoa1411487.
|
| [21] |
Kosiborod M, Peacock WF, Packham DK. Sodium zirconium cyclosilicate for urgent therapy of severe hyperkalemia[J]. N Engl J Med, 2015, 372(16):1577-1578. DOI: 10.1056/NEJMc1500353.
|
Figures(3)
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad:
